| This week's sponsor is IBM Watson Health. | | | Visually Explore Real-world Evidence…
...by disease/product, without programming, statistical, or clinical knowledge. Watch our Video
IBM Access and Value Connect: built on MarketScan® claims and Explorys® EHR databases. |
Today's Rundown Sanofi hires ex-Genentech SVP Berger to head development Audentes loses 2 executives, hires Sangamo CMO to fill vacancy Novartis' asthma combo tops standard of care in phase 3 Navitas Life Sciences buys up KAI Research, adding to later-stage trial offerings With $110M and Johns Hopkins tech, Thrive aims to make early cancer screening routine Bayer taps Roche's Foundation Medicine for Vitrakvi diagnostic development Iovance Biotherapeutics adds to cell therapy manufacturing boom Featured Story | | | Thursday, May 30, 2019 Sanofi has hired Dietmar Berger as head of development. Berger, a cancer specialist, ended his brief stint in biotech earlier this month to return to Big Pharma R&D at Sanofi. |
|
|
Top Stories Thursday, May 30, 2019 Audentes Therapeutics has hired Sangamo Chief Medical Officer Ed Conner to fill one of two vacancies created by the back-to-back departures of members of its C-suite. The departing Audentes executives are CMO Suyash Prasad and Chief Technology Officer John Gray. Thursday, May 30, 2019 Novartis’ asthma treatment combining a long-acting beta agonist with an inhaled corticosteroid improved lung function better than the corticosteroid alone, phase 3 data show. Thursday, May 30, 2019 Contract research organization KAI Research has been snapped up by fellow CRO Navitas Life Sciences as it looks to boost its study offerings. Thursday, May 30, 2019 Steven Kafka, the former Foundation Medicine chief operating officer who landed at Third Rock Ventures after a globetrotting “gap year,” has a new gig: CEO of Thrive Earlier Detection, a liquid biopsy company looking to catch cancer earlier through a routine blood test. Wednesday, May 29, 2019 Bayer has teamed up with Foundation Medicine to develop genetic diagnostic tests for several of its cancer therapies—starting with the tissue-agnostic Vitrakvi in solid tumors with TRK fusion mutations. Wednesday, May 29, 2019 In a transcontinental move, a California biotech working on a cell therapy for solid tumors will build its first manufacturing site in Philadelphia. | This week's sponsor is Medical Sensors Expo & Conference. | | | |
Resources Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. Sponsored by: Catalent Download the executive summary to learn key considerations for a successful technology transfer for manufacturing drug products, including a case study on overcoming challenges in a process transfer for a sterile diluent. Sponsored by: Patheon, part of Thermo Fisher Scientific Choosing the Best Sterile Dosage Form for Your Phase I Clinical Supply Needs. Sponsored by: Patheon, part of Thermo Fisher Scientific Designed with speed & flexibility,Quick to Clinic™ for Oral Solid Dose helps deliver products to Phase I Clinic in as little as 14 weeks. Sponsored by: AlphaSense What is agile competitive intelligence, and how can help healthcare researchers stay ahead of the curve? Sponsored by: JPEO-CBRND – Medical Countermeasure Systems MCS is currently seeking broad-based industry/academia collaboration on research and prototype work in technical areas related to developing medical countermeasures for the Joint Warfighter. Sponsored by: Outer Edge Technology Learn how the cloud can support the performance and security requirements for validated, mission-critical applications historically designed and implemented exclusively via on-premises deployment. Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. 2019 BIO International Convention June 3-6, 2019 | Philadelphia, PA FierceBiotech Executive Breakfast at BIO 2019 – Getting Real: The Changing Tide on Real-World Evidence in Drug Development June 5, 2019 | Philadelphia, PA Medical Sensors Design Conference June 25, 2019 | McEnery Convention Center | San Jose, CA Sensors Expo & Conference June 25-27, 2019 | McEnery Convention Center | San Jose, CA Drug Development Boot Camp® 2019 November 20-21, 2019 | Boston, MA | Register and start preparing Today! | 